Revelation Biosciences, Inc.
REVB
$1.01
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 121.94% | 280.97% | 64.65% | 94.29% | -57.15% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.44% | -58.53% | -20.09% | 5.18% | 47.97% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 118.00% | 261.67% | 64.67% | 92.71% | -56.06% |
|
|
|||||
| Total Current Assets | 118.00% | 261.67% | 64.67% | 92.71% | -56.06% |
| Net Property, Plant & Equipment | 2,123.01% | 1,804.01% | 1,215.10% | -70.57% | -50.28% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 131.65% | 278.92% | 74.92% | 90.74% | -56.03% |
|
|
|||||
| Total Accounts Payable | 12.33% | 32.49% | -26.30% | -66.90% | -35.31% |
| Total Accrued Expenses | 2.74% | 0.97% | 23.68% | -12.31% | -91.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -95.83% | -99.94% |
| Total Other Current Liabilities | -- | -- | -- | -95.83% | -99.94% |
| Total Current Liabilities | 19.82% | 30.07% | 4.42% | -54.40% | -85.90% |
|
|
|||||
| Total Current Liabilities | 19.82% | 30.07% | 4.42% | -54.40% | -85.90% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 54.90% | 88.65% | 42.23% | -54.40% | -85.90% |
|
|
|||||
| Common Stock & APIC | 34.80% | 43.97% | 28.90% | 39.70% | 29.59% |
| Retained Earnings | -23.89% | -23.20% | -22.01% | -20.96% | -23.16% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 163.13% | 350.88% | 88.20% | 311.50% | 235.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 163.13% | 350.88% | 88.20% | 311.50% | 235.48% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 163.13% | 350.88% | 88.20% | 311.50% | 235.48% |
|
|
|||||